| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Combs Andrew | EVP, Head of Chemistry | Mar 31, 2022 | Option Exercise | $1.89 | 36,062 | 68,157 | 304,442 | Apr 04, 2022, 05:08 PM | |
| PRLD | Prelude Therapeutics Inc | Combs Andrew | EVP, Head of Chemistry | Dec 14, 2021 | Buy | $11.60 | 4,000 | 46,400 | 268,380 | Dec 15, 2021, 05:21 PM | |
| PRLD | Prelude Therapeutics Inc | Combs Andrew | EVP, Head of Chemistry | Dec 13, 2021 | Buy | $12.12 | 4,000 | 48,480 | 264,380 | Dec 15, 2021, 05:21 PM | |
| PRLD | Prelude Therapeutics Inc | Combs Andrew | EVP, Head of Chemistry | Sep 29, 2020 | Buy | $19.00 | 1,000 | 19,000 | 260,380 | Sep 29, 2020, 08:11 PM |
Menu